Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omotayo Fasan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2013
Optimal autologous peripheral blood progenitor cell mobilization involves more than the CD34+yieldOmotayo Fasan
Current Opinion in Hematology|September 11, 2019
Using minimal (measurable) residual disease assessments to guide decision-making for timing of allogeneic transplantation in acute myeloid leukemiaOmotayo Fasan
Thrombosis and Haemostasis|December 4, 2003
Thrombolysis in pregnancyRak K Patel, Omotayo Fasan, Roopen Arya
Cancer Management and Research|May 23, 2015
Expanding role of lenalidomide in hematologic malignanciesNilanjan Ghosh, Michael R Grunwald, Omotayo Fasan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2013
Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patientsMeghan Karuturi, Nirav Shah, Dale Frank, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Journal of Clinical Apheresis|March 12, 2021
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantationSrinivasa Reddy Sanikommu, Emily S Reese, Jiaxian He, et al.
The Oncologist|October 29, 2017
<i>ALK</i> Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted TherapyJeffrey S Ross, Siraj M Ali, Omotayo Fasan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mei-Jie Zhang, Shannon R McCurdy, et al.
JAMA Network Open|January 15, 2026
Air Pollution and Cardiac Remodeling and Function in Patients With Breast CancerWonyoung Jung, Kyunga Ko, Amanda M Smith, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2013
Optimal autologous peripheral blood progenitor cell mobilization involves more than the CD34+yieldOmotayo Fasan
Current Opinion in Hematology|September 11, 2019
Using minimal (measurable) residual disease assessments to guide decision-making for timing of allogeneic transplantation in acute myeloid leukemiaOmotayo Fasan
Thrombosis and Haemostasis|December 4, 2003
Thrombolysis in pregnancyRak K Patel, Omotayo Fasan, Roopen Arya
Cancer Management and Research|May 23, 2015
Expanding role of lenalidomide in hematologic malignanciesNilanjan Ghosh, Michael R Grunwald, Omotayo Fasan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2013
Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patientsMeghan Karuturi, Nirav Shah, Dale Frank, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Journal of Clinical Apheresis|March 12, 2021
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantationSrinivasa Reddy Sanikommu, Emily S Reese, Jiaxian He, et al.
The Oncologist|October 29, 2017
<i>ALK</i> Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted TherapyJeffrey S Ross, Siraj M Ali, Omotayo Fasan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mei-Jie Zhang, Shannon R McCurdy, et al.
JAMA Network Open|January 15, 2026
Air Pollution and Cardiac Remodeling and Function in Patients With Breast CancerWonyoung Jung, Kyunga Ko, Amanda M Smith, et al.
Pageof 2